Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations

Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations

To correlate the differentially expressed miRNAs with clinico-pathological features in uveal melanoma (UM) tumors harbouring chromosomal 3 aberrations among South Asian Indian cohort.Based on chromosomal 3 aberration, UM (n = 86) were grouped into monosomy 3 (M3; n = 51) and disomy 3 (D3; n = 35) by...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Nalini Venkatesan, Jagat R. Kanwar, Perinkulam Ravi Deepa, Vikas Khetan, Tamsyn M. Crowley, Rajeswari Raguraman, Ganesan Sugneswari, Pukhraj Rishi, Viswanathan Natarajan, Jyotirmay Biswas, Subramanian Krishnakumar
Hōputu:	Artigo
Reo:	Ingarihi
I whakaputaina:	2016
Urunga tuihono:	https://doi.org/10.1371/journal.pone.0146128 https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0146128&type=printable
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Targeting HMGA2 in Retinoblastoma Cells in vitro Using the Aptamer Strategy
mā: Nalini, Venkatesan, me ētahi atu.
I whakaputaina: (2016)

Evidence of Tumour Microenvironment and Stromal Cellular Components in Retinoblastoma
mā: Raguraman, Rajeswari, me ētahi atu.
I whakaputaina: (2019)

Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal Melanomas
mā: Mobuchon, Lenha, me ētahi atu.
I whakaputaina: (2021)

Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy
mā: Venkatesan, Nalini, me ētahi atu.
I whakaputaina: (2015)

Computational and<i>in vitro</i>Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy
mā: Nalini Venkatesan, me ētahi atu.
I whakaputaina: (2015)

Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma
mā: Mergener, Svenja, me ētahi atu.
I whakaputaina: (2021)

Molecular Insights on Post-chemotherapy Retinoblastoma by Microarray Gene Expression Analysis
mā: Nalini, Venkatesan, me ētahi atu.
I whakaputaina: (2013)

EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer
mā: Nithya Subramanian, me ētahi atu.
I whakaputaina: (2015)

Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells
mā: Venkatesan, Nalini, me ētahi atu.
I whakaputaina: (2012)

EpCAM Knockdown Alters MicroRNA Expression in Retinoblastoma- Functional Implication of EpCAM Regulated MiRNA in Tumor Progression
mā: Beta, Madhu, me ētahi atu.
I whakaputaina: (2014)

Monosomy 3 by chromogenic in situ hybridization (CISH) in Iranian patients with uveal melanoma
mā: Naseripour, Masood, me ētahi atu.
I whakaputaina: (2015)

Uveal Melanoma Regression after Brachytherapy: Relationship with Chromosome 3 Monosomy Status
mā: Salvi, Sachin M., me ētahi atu.
I whakaputaina: (2017)

Monosomy-3 Alters the Expression Profile of the Glucose Transporters GLUT1-3 in Uveal Melanoma
mā: Maaßen, Tjorge, me ētahi atu.
I whakaputaina: (2020)

EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer
mā: Subramanian, Nithya, me ētahi atu.
I whakaputaina: (2015)

Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3
mā: Tura, Aysegül, me ētahi atu.
I whakaputaina: (2020)

Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma
mā: Radhakrishnan, Abhirami, me ētahi atu.
I whakaputaina: (2009)

Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma
mā: Triozzi, Pierre L., me ētahi atu.
I whakaputaina: (2016)

Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival
mā: Abdel-Rahman, Mohamed H., me ētahi atu.
I whakaputaina: (2012)

Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival
mā: Mohamed H. Abdel‐Rahman, me ētahi atu.
I whakaputaina: (2012)

Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma
mā: Pierre L. Triozzi, me ētahi atu.
I whakaputaina: (2016)

MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3
mā: Souri, Zahra, me ētahi atu.
I whakaputaina: (2021)

Loss of Heterozygosity of Chromosome 3 Detected with Single Nucleotide Polymorphisms Is Superior to Monosomy 3 for Predicting Metastasis in Uveal Melanoma
mā: Michael D. Onken, me ētahi atu.
I whakaputaina: (2007)

Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry–based imaging
mā: Subramanian, Nithya, me ētahi atu.
I whakaputaina: (2016)

Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy
mā: Soltysova, Andrea, me ētahi atu.
I whakaputaina: (2020)

Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors
mā: Papastefanou, Vasilios P, me ētahi atu.
I whakaputaina: (2014)

Metastasis of Uveal Melanoma with Monosomy-3 Is Associated with a Less Glycogenetic Gene Expression Profile and the Dysregulation of Glycogen Storage
mā: Vardanyan, Siranush, me ētahi atu.
I whakaputaina: (2020)

Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3
mā: Martin, Marcel, me ētahi atu.
I whakaputaina: (2013)

Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3
mā: Marcel Martin, me ētahi atu.
I whakaputaina: (2013)

RNAi Mediated Tiam1 Gene Knockdown Inhibits Invasion of Retinoblastoma
mā: Subramanian, Nithya, me ētahi atu.
I whakaputaina: (2013)

Small Choroidal Melanoma with Monosomy 3
mā: Ghassemi, Fariba, me ētahi atu.
I whakaputaina: (2010)

EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
mā: Nithya Subramanian, me ētahi atu.
I whakaputaina: (2015)

Atypical Presentation of Bilateral Retinoblastoma with Floaters and Sub-Internal Limiting Membrane Seeds in an 11-Year-Old Asian Indian Male
mā: Rishi, Pukhraj, me ētahi atu.
I whakaputaina: (2018)

Plaque radiation for ciliary body medulloepithelioma presenting with neovascular glaucoma and vitreous hemorrhage in 13-year-old Asian girl
mā: Attiku, Yamini, me ētahi atu.
I whakaputaina: (2020)

Intraocular IgG4 disease masquerading as nodular scleritis
mā: Attiku, Yamini, me ētahi atu.
I whakaputaina: (2020)

MYD88 L265P mutation in intraocular lymphoma: A potential diagnostic marker
mā: Narasimhan, Sandhya, me ētahi atu.
I whakaputaina: (2020)

Trisomy 1q41-qter and monosomy 3p26.3-pter in a family with a translocation (1;3): further delineation of the syndromes
mā: Cervantes, Alicia, me ētahi atu.
I whakaputaina: (2014)

Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer
mā: Subramanian, Nithya, me ētahi atu.
I whakaputaina: (2012)

Identification and Insilico Analysis of Retinoblastoma Serum microRNA Profile and Gene Targets Towards Prediction of Novel Serum Biomarkers
mā: Beta, Madhu, me ētahi atu.
I whakaputaina: (2013)

Identification and Insilico Analysis of Retinoblastoma Serum microRNA Profile and Gene Targets towards Prediction of Novel Serum Biomarkers
mā: Madhu Beta, me ētahi atu.
I whakaputaina: (2013)

Retinal Pigment Epithelium Adenoma and Adenocarcinoma: A Review
mā: Sreenivasan, Janani, me ētahi atu.
I whakaputaina: (2021)